Vaccine news: Fluarix Quadrivalent four-strain flu vaccine receives FDA approval for expanded use in children as young as 6 months old
by Press Release from Outbreak News Today on (#3D6EM)
GlaxoSmithKline (GSK) announced Friday it has received approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research expanding the indication for FLUARIX(R) QUADRIVALENT (Influenza Vaccine) to include use in persons 6 months and older. Prior to this, the vaccine was only approved for active immunization against influenza A subtype viruses and type B ["]
The post Vaccine news: Fluarix Quadrivalent four-strain flu vaccine receives FDA approval for expanded use in children as young as 6 months old appeared first on Outbreak News Today.